/PRNewswire/ Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying.
SALT LAKE CITY, Sept. 05, 2023 Recursion , a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor.
Stocks To Watch: Conferences And Federal Reserve To Dominate Holiday-Shortened Week seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.